Hologic stock holds near a 52-week high after latest earnings
Published on 08/26/2026 at 11:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Hologic, Inc. (US4364401012) stock is trading near a 52-week high at $76.07 as of August 24, 2026, with a market value of $16.97 billion and a trailing P/E ratio of 31.67. The company last reported earnings on January 29, 2026, and the latest snapshot shows trailing twelve-month EPS of $2.40.
Price and valuation
The share price sits at the top end of a 52-week range from $51.90 to $76.07, which leaves the stock close to its high rather than its low. That same quote implies the market is paying 31.67 times trailing earnings, while the forward P/E stands at 17.76.
MarketBeat data show volume at 102.03 million shares, far above the 3.29 million average, a sign that turnover has been unusually heavy. The same source also shows a consensus rating of Hold and a price target of $79.13, only modestly above the latest quote.
Latest earnings picture
The most recent quarterly filing snapshot says Hologic reported $1.04 in EPS for the quarter ended January 29, 2026, missing the $1.09 consensus by $0.05. Revenue in that quarter rose 2.5 percent year over year, and net income over the trailing twelve months reached $565.70 million with a 13.18 percent margin.
For investors, the gap between the 31.67 trailing P/E and the 17.76 forward P/E is the key valuation clue. It points to expectations for EPS expansion during fiscal 2026, even after the January quarter miss.
Business context
Hologic's medical technology lineup spans diagnostics, breast health and surgical products, with diagnostics still central to the company's profile. That mix matters because the January 29, 2026 earnings update tied the stock's valuation to a business that already generated $565.70 million in trailing net income and $2.40 in trailing EPS.
The most recent market setup is simple: a $76.07 share price, a $16.97 billion market cap and a 52-week range capped at $76.07. Those figures leave little room between the quote and the high, so the next move will be judged against that level.
More on Hologic stock
Hologic's best-known products include the Aptima molecular diagnostics platform and the company's breast imaging and surgical systems. Those products anchor a business that investors are currently valuing against a forward P/E of 17.76 and a trailing P/E of 31.67.
Hologic shares
As of August 24, 2026, Hologic shares were at $76.07 on Nasdaq. The market value was $16.97 billion on that same date, while the quote also matched the top of the 52-week range at $76.07.
Fact box
Company: Hologic, Inc.
ISIN: US4364401012
Ticker: HOLX
Exchange: Nasdaq
Price (as of August 24, 2026, 4:00 p.m. ET): $76.07 USD
Market cap: $16.97 billion (as of August 24, 2026)
Sector / Industry: Healthcare / Healthcare Equipment & Supplies
Index membership: S&P 500
